List of Excipients in API IMATINIB MESYLATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing IMATINIB MESYLATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | GLEEVEC | imatinib mesylate | 0078-0401 | CELLULOSE, MICROCRYSTALLINE | |
| Novartis Pharmaceuticals Corporation | GLEEVEC | imatinib mesylate | 0078-0401 | CROSPOVIDONE | |
| Novartis Pharmaceuticals Corporation | GLEEVEC | imatinib mesylate | 0078-0401 | FERRIC OXIDE RED | |
| Novartis Pharmaceuticals Corporation | GLEEVEC | imatinib mesylate | 0078-0401 | FERRIC OXIDE YELLOW | |
| Novartis Pharmaceuticals Corporation | GLEEVEC | imatinib mesylate | 0078-0401 | HYPROMELLOSES | |
| Novartis Pharmaceuticals Corporation | GLEEVEC | imatinib mesylate | 0078-0401 | MAGNESIUM STEARATE | |
| Novartis Pharmaceuticals Corporation | GLEEVEC | imatinib mesylate | 0078-0401 | POLYETHYLENE GLYCOL 4000 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing IMATINIB MESYLATE
Detailed excipient profiles for IMATINIB MESYLATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
IMATINIB MESYLATE drug variants containing CELLULOSE, MICROCRYSTALLINE
IMATINIB MESYLATE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: COPOVIDONE K25-31
IMATINIB MESYLATE drug variants containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar RxLLC | imatinib mesylate | 16714-704 |
| Sun Pharmaceutical Industries Inc | imatinib mesylate | 47335-472 |
| American Health Packaging | imatinib mesylate | 60687-192 |
| BluePoint Laboratories | imatinib mesylate | 68001-490 |
| >Company | >Ingredient | >NDC |
IMATINIB MESYLATE drug variants not containing COPOVIDONE K25-31
Excipient focus: CROSCARMELLOSE SODIUM
IMATINIB MESYLATE drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | imatinib mesylate | 0093-7629 |
| Golden State Medical Supply Inc | imatinib mesylate | 60429-925 |
| Zydus Pharmaceuticals USA Inc | imatinib mesylate | 68382-244 |
| Zydus Lifesciences Limited | imatinib mesylate | 70771-1394 |
| >Company | >Ingredient | >NDC |
IMATINIB MESYLATE drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
IMATINIB MESYLATE drug variants containing CROSPOVIDONE
IMATINIB MESYLATE drug variants not containing CROSPOVIDONE
Excipient focus: FD&C YELLOW NO. 6
IMATINIB MESYLATE drug variants containing FD&C YELLOW NO. 6
IMATINIB MESYLATE drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
IMATINIB MESYLATE drug variants containing FERRIC OXIDE RED
IMATINIB MESYLATE drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
IMATINIB MESYLATE drug variants containing FERRIC OXIDE YELLOW
IMATINIB MESYLATE drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
IMATINIB MESYLATE drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | imatinib mesylate | 0093-7629 |
| Major Pharmaceuticals | imatinib mesylate | 0904-6901 |
| AvPAK | imatinib mesylate | 50268-426 |
| Golden State Medical Supply Inc | imatinib mesylate | 60429-925 |
| Apotex Corp | imatinib mesylate | 60505-2900 |
| >Company | >Ingredient | >NDC |
IMATINIB MESYLATE drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
IMATINIB MESYLATE drug variants containing HYPROMELLOSE
IMATINIB MESYLATE drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
IMATINIB MESYLATE drug variants containing HYPROMELLOSE 2910
IMATINIB MESYLATE drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
IMATINIB MESYLATE drug variants containing HYPROMELLOSES
IMATINIB MESYLATE drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE MONOHYDRATE
IMATINIB MESYLATE drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | imatinib mesylate | 0093-7629 |
| Golden State Medical Supply Inc | imatinib mesylate | 60429-925 |
| >Company | >Ingredient | >NDC |
IMATINIB MESYLATE drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
IMATINIB MESYLATE drug variants containing MAGNESIUM STEARATE
IMATINIB MESYLATE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
IMATINIB MESYLATE drug variants containing MANNITOL
IMATINIB MESYLATE drug variants not containing MANNITOL
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
IMATINIB MESYLATE drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | imatinib mesylate | 59651-240 |
| QUALLENT PHARMACEUTICALS HEALTH LLC | imatinib mesylate | 82009-086 |
| >Company | >Ingredient | >NDC |
IMATINIB MESYLATE drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: MICROCRYSTALLINE CELLULOSE 200
IMATINIB MESYLATE drug variants containing MICROCRYSTALLINE CELLULOSE 200
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | imatinib mesylate | 59651-240 |
| QUALLENT PHARMACEUTICALS HEALTH LLC | imatinib mesylate | 82009-086 |
| >Company | >Ingredient | >NDC |
IMATINIB MESYLATE drug variants not containing MICROCRYSTALLINE CELLULOSE 200
Excipient focus: POLYETHYLENE GLYCOL
IMATINIB MESYLATE drug variants containing POLYETHYLENE GLYCOL
IMATINIB MESYLATE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
IMATINIB MESYLATE drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | imatinib mesylate | 59651-240 |
| Archis Pharma LLC | imatinib mesylate | 72819-185 |
| QUALLENT PHARMACEUTICALS HEALTH LLC | imatinib mesylate | 82009-086 |
| >Company | >Ingredient | >NDC |
IMATINIB MESYLATE drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 4000
IMATINIB MESYLATE drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | imatinib mesylate | 0078-0401 |
| >Company | >Ingredient | >NDC |
IMATINIB MESYLATE drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYETHYLENE GLYCOL 8000
IMATINIB MESYLATE drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith Laboratories LLC | imatinib mesylate | 0832-0532 |
| Major Pharmaceuticals | imatinib mesylate | 0904-6901 |
| AvPAK | imatinib mesylate | 50268-426 |
| Apotex Corp | imatinib mesylate | 60505-2900 |
| Qilu Pharmaceutical Co Ltd | imatinib mesylate | 67184-0532 |
| >Company | >Ingredient | >NDC |
IMATINIB MESYLATE drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYVINYL ALCOHOL
IMATINIB MESYLATE drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | imatinib mesylate | 0054-0248 |
| >Company | >Ingredient | >NDC |
IMATINIB MESYLATE drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE
IMATINIB MESYLATE drug variants containing POVIDONE
IMATINIB MESYLATE drug variants not containing POVIDONE
Excipient focus: SILICON DIOXIDE
IMATINIB MESYLATE drug variants containing SILICON DIOXIDE
IMATINIB MESYLATE drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM STEARYL FUMARATE
IMATINIB MESYLATE drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | imatinib mesylate | 0093-7629 |
| Golden State Medical Supply Inc | imatinib mesylate | 60429-925 |
| >Company | >Ingredient | >NDC |
IMATINIB MESYLATE drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: TALC
IMATINIB MESYLATE drug variants containing TALC
IMATINIB MESYLATE drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
IMATINIB MESYLATE drug variants containing TITANIUM DIOXIDE
IMATINIB MESYLATE drug variants not containing TITANIUM DIOXIDE
Excipient focus: WATER
IMATINIB MESYLATE drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | imatinib mesylate | 0078-0401 |
| Upsher-Smith Laboratories LLC | imatinib mesylate | 0832-0532 |
| Qilu Pharmaceutical Co Ltd | imatinib mesylate | 67184-0532 |
| >Company | >Ingredient | >NDC |
IMATINIB MESYLATE drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
